515 related articles for article (PubMed ID: 28339885)
1. Alcohol-related hospitalization is associated with increased risk of ischaemic stroke among low-risk patients with atrial fibrillation.
Al-Khalili F; Benson L; Friberg L
Europace; 2018 Jan; 20(1):19-24. PubMed ID: 28339885
[TBL] [Abstract][Full Text] [Related]
2. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
Wicke FS; Schaller MA; Karymova K; Beyer M; Müller BS
BMC Cardiovasc Disord; 2019 Apr; 19(1):94. PubMed ID: 31014253
[TBL] [Abstract][Full Text] [Related]
3. Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis.
Chan PH; Huang D; Yip PS; Hai J; Tse HF; Chan TM; Lip GY; Lo WK; Siu CW
Europace; 2016 May; 18(5):665-71. PubMed ID: 26504109
[TBL] [Abstract][Full Text] [Related]
4. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study.
Hu WS; Lin CL
Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study.
Yoon M; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
Thromb Haemost; 2018 Jul; 118(7):1296-1304. PubMed ID: 29723875
[TBL] [Abstract][Full Text] [Related]
6. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.
Friberg L; Skeppholm M; Terént A
J Am Coll Cardiol; 2015 Jan; 65(3):225-32. PubMed ID: 25614418
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation in patients with ischaemic stroke in the Swedish national patient registers: how much do we miss?
Baturova MA; Lindgren A; Carlson J; Shubik YV; Bertil Olsson S; Platonov PG
Europace; 2014 Dec; 16(12):1714-9. PubMed ID: 25013011
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation - A Nationwide Cohort Study.
Jung H; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Sung JH; Pak HN; Lee MH; Lip GYH; Joung B
Circ J; 2019 Nov; 83(12):2547-2554. PubMed ID: 31619594
[TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure.
Hamatani Y; Iguchi M; Nakamura M; Ohtani R; Yamashita Y; Takagi D; Unoki T; Ishii M; Masunaga N; Ogawa H; Hamatani M; Abe M; Akao M
Heart Vessels; 2016 Jul; 31(7):1154-61. PubMed ID: 26219729
[TBL] [Abstract][Full Text] [Related]
10. Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
Baturova MA; Lindgren A; Carlson J; Shubik YV; Olsson SB; Platonov PG
Int J Cardiol; 2015 Nov; 199():248-52. PubMed ID: 26209828
[TBL] [Abstract][Full Text] [Related]
11. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study.
Chen YL; Lin YS; Wang HT; Liu WH; Chen HC; Chen MC
Europace; 2019 Feb; 21(2):313-321. PubMed ID: 30107472
[TBL] [Abstract][Full Text] [Related]
13. Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry.
Ding WY; Blomström-Lundqvist C; Fauchier L; Marin F; Potpara TS; Boriani G; Lip GYH
Europace; 2023 Feb; 25(2):277-282. PubMed ID: 36427202
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Friberg L; Rosenqvist M; Lip GY
Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex).
Xie X; Li T
Acta Cardiol; 2021 May; 76(3):258-264. PubMed ID: 32056508
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Use vs Discontinuation of Oral Anticoagulation After Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
Själander S; Holmqvist F; Smith JG; Platonov PG; Kesek M; Svensson PJ; Blomström-Lundqvist C; Tabrizi F; Tapanainen J; Poci D; Jönsson A; Själander A
JAMA Cardiol; 2017 Feb; 2(2):146-152. PubMed ID: 27893055
[TBL] [Abstract][Full Text] [Related]
17. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
18. Oral anticoagulation in patients with atrial fibrillation and acute ischaemic stroke: design and baseline data of the prospective multicentre Berlin Atrial Fibrillation Registry.
Haeusler KG; Tütüncü S; Kunze C; Schurig J; Malsch C; Harder J; Wiedmann S; Dimitrijeski B; Ebinger M; Hagemann G; Hamilton F; Honermann M; Jungehulsing GJ; Kauert A; Koennecke HC; Leithner C; Mackert BM; Masuhr F; Nabavi D; Rocco A; Schmehl I; Schmitz B; Sparenberg P; Stingele R; von Brevern M; Völzke E; Dietzel J; Heuschmann PU; Endres M
Europace; 2019 Nov; 21(11):1621-1632. PubMed ID: 31397475
[TBL] [Abstract][Full Text] [Related]
19. Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study.
Nielsen PB; Overvad TF; Andersen SD; Larsen TB; Skjøth F; Søgaard M; Lip GYH
Cerebrovasc Dis; 2019; 48(3-6):236-243. PubMed ID: 31846970
[TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.
Lip GY; Skjøth F; Rasmussen LH; Larsen TB
J Am Coll Cardiol; 2015 Apr; 65(14):1385-94. PubMed ID: 25770314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
